148 related articles for article (PubMed ID: 20467564)
1. Role of angiopoietin-2 in regulating growth and vascularity of astrocytomas.
Zadeh G; Koushan K; Baoping Q; Shannon P; Guha A
J Oncol; 2010; 2010():659231. PubMed ID: 20467564
[TBL] [Abstract][Full Text] [Related]
2. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2.
Teichert-Kuliszewska K; Maisonpierre PC; Jones N; Campbell AI; Master Z; Bendeck MP; Alitalo K; Dumont DJ; Yancopoulos GD; Stewart DJ
Cardiovasc Res; 2001 Feb; 49(3):659-70. PubMed ID: 11166279
[TBL] [Abstract][Full Text] [Related]
3. Fetoplacental regional variations in the expression of angiopoietin-1, angiopoietin-2, and Tie2 in normal-term and near-term pregnancies.
De A; Maulik D; Lankachandra K; Mundy DC; Ye SQ; Gerkovich MM
J Matern Fetal Neonatal Med; 2016 Nov; 29(21):3421-8. PubMed ID: 26752164
[TBL] [Abstract][Full Text] [Related]
4. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization.
Asahara T; Chen D; Takahashi T; Fujikawa K; Kearney M; Magner M; Yancopoulos GD; Isner JM
Circ Res; 1998 Aug; 83(3):233-40. PubMed ID: 9710115
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
6. Effects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surface.
Hansen TM; Singh H; Tahir TA; Brindle NP
Cell Signal; 2010 Mar; 22(3):527-32. PubMed ID: 19922791
[TBL] [Abstract][Full Text] [Related]
7. Ligand oligomerization state controls Tie2 receptor trafficking and angiopoietin-2-specific responses.
Pietilä R; Nätynki M; Tammela T; Kangas J; Pulkki KH; Limaye N; Vikkula M; Koh GY; Saharinen P; Alitalo K; Eklund L
J Cell Sci; 2012 May; 125(Pt 9):2212-23. PubMed ID: 22357955
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of Angiopoietins and their tie receptors in human basophils and mast cells.
Prevete N; Staiano RI; Granata F; Detoraki A; Necchi V; Ricci V; Triggiani M; De Paulis A; Marone G; Genovese A
J Biol Regul Homeost Agents; 2013; 27(3):827-39. PubMed ID: 24152847
[TBL] [Abstract][Full Text] [Related]
9. Expression and hypoxic regulation of angiopoietins in human astrocytomas.
Ding H; Roncari L; Wu X; Lau N; Shannon P; Nagy A; Guha A
Neuro Oncol; 2001 Jan; 3(1):1-10. PubMed ID: 11305411
[TBL] [Abstract][Full Text] [Related]
10. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.
Koga K; Todaka T; Morioka M; Hamada J; Kai Y; Yano S; Okamura A; Takakura N; Suda T; Ushio Y
Cancer Res; 2001 Aug; 61(16):6248-54. PubMed ID: 11507079
[TBL] [Abstract][Full Text] [Related]
11. Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels.
Falcón BL; Hashizume H; Koumoutsakos P; Chou J; Bready JV; Coxon A; Oliner JD; McDonald DM
Am J Pathol; 2009 Nov; 175(5):2159-70. PubMed ID: 19815705
[TBL] [Abstract][Full Text] [Related]
12. Angiopoietins Modulate Survival, Migration, and the Components of the Ang-Tie2 Pathway of Chronic Lymphocytic Leukaemia (CLL) Cells In Vitro.
Aguirre Palma LM; Flamme H; Gerke I; Kreuzer KA
Cancer Microenviron; 2016 Apr; 9(1):13-26. PubMed ID: 26846110
[TBL] [Abstract][Full Text] [Related]
13. Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancer.
Hata K; Udagawa J; Fujiwaki R; Nakayama K; Otani H; Miyazaki K
Oncology; 2002; 62(4):340-8. PubMed ID: 12138242
[TBL] [Abstract][Full Text] [Related]
14. Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition.
Daly C; Eichten A; Castanaro C; Pasnikowski E; Adler A; Lalani AS; Papadopoulos N; Kyle AH; Minchinton AI; Yancopoulos GD; Thurston G
Cancer Res; 2013 Jan; 73(1):108-18. PubMed ID: 23149917
[TBL] [Abstract][Full Text] [Related]
15. Expressions of Angiopoietin-1, Angiopoietin-2, and Tie2 and their roles in rat renal allografts with chronic allograft nephropathy.
Ma X; Lu YP; Yang L; Song J; Luo GH; Shi YJ; Li YP
Transplant Proc; 2008 Oct; 40(8):2795-9. PubMed ID: 18929864
[TBL] [Abstract][Full Text] [Related]
16. Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth.
Hawighorst T; Skobe M; Streit M; Hong YK; Velasco P; Brown LF; Riccardi L; Lange-Asschenfeldt B; Detmar M
Am J Pathol; 2002 Apr; 160(4):1381-92. PubMed ID: 11943723
[TBL] [Abstract][Full Text] [Related]
17. Expression of angiopoietin-1 in human glioblastomas regulates tumor-induced angiogenesis: in vivo and in vitro studies.
Audero E; Cascone I; Zanon I; Previtali SC; Piva R; Schiffer D; Bussolino F
Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):536-41. PubMed ID: 11304469
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium.
Yuan HT; Khankin EV; Karumanchi SA; Parikh SM
Mol Cell Biol; 2009 Apr; 29(8):2011-22. PubMed ID: 19223473
[TBL] [Abstract][Full Text] [Related]
19. Adrenocorticotropin preferentially up-regulates angiopoietin 2 in the human fetal adrenal gland: implications for coordinated adrenal organ growth and angiogenesis.
Ishimoto H; Ginzinger DG; Jaffe RB
J Clin Endocrinol Metab; 2006 May; 91(5):1909-15. PubMed ID: 16492693
[TBL] [Abstract][Full Text] [Related]
20. Characterization and expression of a novel alternatively spliced human angiopoietin-2.
Kim I; Kim JH; Ryu YS; Jung SH; Nah JJ; Koh GY
J Biol Chem; 2000 Jun; 275(24):18550-6. PubMed ID: 10766762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
